Announcements of draconian cuts to the federal workforce, accompanied by the elimination of entire federal agencies, offices and programs, are being issued so repeatedly from the Trump administration ...
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...
Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.
Stocks like Reliance Industries, Apollo Hospitals Enterprise, Power Grid Corporation, Allied Blenders and Distillers, ...
Nikhat attended the trailer launch of her upcoming Malayalam film, L2: Empuraan, in Mumbai. On the sidelines of the event, ...
After more than a decade of negotiations, a new round of talks to finalize a code to regulate deep-sea mining in ...
Stocks like Quality Power Electrical Equipments, Dr Reddy’s Laboratories, Tata Motors, Voltas, Tejas Networks, KPIT ...
The Office of Personnel Management (OPM), the Social Security Administration, and the Department of Health and Human Services (HHS), including its Food and Drug Administration (FDA), are among the ...
The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...
But the US Food and Drug Administration (FDA) has now declared those shortages over. Compounding pharmacies will soon have to stop selling their mass-produced versions — at least, in theory.
Last year, Valisure filed a petition with the US FDA calling for the regulator to recall products, investigate, and revise industry guidance. So far, the FDA has not responded. Previously, testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback